Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q4 2020 · 10-K
Revenue$264.91M$264.91M+55.3% vs Q4 2019 Net Income$27.99M$27.99M+40.8% vs Q4 2019 EPS Diluted$2.36$2.36+42.2% vs Q4 2019 Gross Profit$199,239,000+55.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$19,829,000+3.5% Free Cash Flowderived$17,794,000−2.9% Margins · derivedGross margin75.2%+0.2 pt vs Q4 2019
Operating margin14.3%+3.4 pt vs Q4 2019
Net margin10.6%−1.1 pt vs Q4 2019
ended Dec 31, 2020 · filed Feb 26, 2021 · 57 d after period end